Congxiang Zhang
Research Subjects
Congxiang Zhang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Dezhong Yao
National Supercomputing Center in Zhengzhou
1 shared publicationDujuan Zhang
National Supercomputing Center in Zhengzhou
1 shared publication- Gang Wu
School of Computer and Artificial Intelligence, ZhengZhou University, Zhengzhou, China
1 shared publication - Hengliang Guo
School of Computer and Artificial Intelligence, Zhengzhou University, China
1 shared publication Jiandong Shang
National Supercomputing Center in Zhengzhou
1 shared publicationKang Gao
National Supercomputing Center in Zhengzhou
1 shared publication
Latest Publications
- 31 March 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (7) , 3749-3760
Drug-Target Affinity Prediction Based on Topological Enhanced Graph Neural Networks
Graph neural networks (GNNs) have achieved remarkable success in drug-target affinity (DTA) analysis, reducing the cost of drug development. Unlike traditional one-dimensional (1D) sequence-based methods, GNNs leverage graph structures to capture richer protein and drug features, leading to improved DTA prediction performance. However, existing methods often neglect to incorporate valuable protein cavity information, a key aspect of protein physical chemistry. This study addresses this gap by proposing a novel topology-enhanced GNN for DTA prediction that integrates protein pocket data. Additionally, we optimize training and message-passing strategies to enhance the model's feature representation capabilities. Our model's effectiveness is validated on the Davis and KIBA data sets, demonstrating its ability to capture the intricate interplay between drugs and targets. The source code is publicly available on https://github.com/ZZDXgangwu/DTA.
- 31 March 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (7) , 3749-3760
Drug-Target Affinity Prediction Based on Topological Enhanced Graph Neural Networks
Graph neural networks (GNNs) have achieved remarkable success in drug-target affinity (DTA) analysis, reducing the cost of drug development. Unlike traditional one-dimensional (1D) sequence-based methods, GNNs leverage graph structures to capture richer protein and drug features, leading to improved DTA prediction performance. However, existing methods often neglect to incorporate valuable protein cavity information, a key aspect of protein physical chemistry. This study addresses this gap by proposing a novel topology-enhanced GNN for DTA prediction that integrates protein pocket data. Additionally, we optimize training and message-passing strategies to enhance the model's feature representation capabilities. Our model's effectiveness is validated on the Davis and KIBA data sets, demonstrating its ability to capture the intricate interplay between drugs and targets. The source code is publicly available on https://github.com/ZZDXgangwu/DTA.